Page 2 - Presented March News Today

Athletes with a diagnosed genetic heart disease should not automatically be banned from participating in elite-level sports, as has previously been recommended, a new study suggests.

Although the rate of injuries among youth have dropped since 2006, the incidence of head and neck trauma and recuperation times are on the rise.

The findings challenge pacing recommendations in HFpEF with chronotropic incompetence and should highlight the disorders systemic nature, say observers.

When a 68-year-old man in Norway died of infection after a transrectal biopsy, his daughter urged change. Four years later, that campaign looks to be a success ― but the US has moved slowly to adapt.

Photodynamic diagnosis-guided TURBT did not reduce 3-year recurrence rates of non–muscle-invasive bladder cancer in a real-world trial compared with white light-guided cystoscopy.

ECT in older patients with refractory depression and bipolar disorder has been linked to cognitive improvement, allaying fears that the treatment could have a deleterious impact in this patient population.

A new oral formulation of a PCSK9-inhibitor, cholesterol-lowering drug has shown encouraging results in a phase 2 study.

For older patients with resistant depression who fail to respond to antidepressants, the addition of atypical antipsychotic aripiprazole is superior to switching antidepressants, new research suggests.

The 3-year results show that low-surgical-risk patients undergoing aortic valve replacement continue to show lower rates of all-cause mortality and disabling stroke with TAVR compared with surgery.

Immediate complete revascularization during the index procedure might become the new treatment paradigm in patients with ACS and multivessel disease, results of the BIOVASC trial suggest.